Literature DB >> 25505361

AMINO ACID LEVELS IN PRADER-WILLI SYNDROME AND OBESE INDIVIDUALS.

Merlin G Butler1, Joel E Murrell2, Harry L Greene2.   

Abstract

To determine if certain features (e.g., hypopigmentation) seen in persons with Prader-Willi syndrome (PWS) may be reflected in abnormalities of amino acid metabolism, fasting plasma amino acid levels were measured from 25 patients and compared with those in 17 obese individuals. Thirteen of the patients with PWS were previously identified by high-resolution analysis to have chromosome 15q deletion, while 12 had normal chromosomes. Compared with reference plasma levels, several amino acid levels were elevated in both patients and obese individuals. Aspartic acid, taurine, and glutamic acid levels were elevated (>2 Z score) in 44% of the patients with PWS but were increased in only one obese individual. The average phenylalanine and tyrosine levels were not different in the two groups. Significant differences in taurine, cystine, glutamic acid, citrulline, and aspartic acid levels were found. There was no correlation with age, degree of obesity (percentage of ideal body weight), and the degree of elevation of amino acids in either patients with PWS or obese individuals. Similarly, the degree of obesity in those with PWS was not associated with chromosome status. Several amino acid concentrations were abnormal in patients compared with our laboratory reference ranges, but many of these abnormalities were also present in obese individuals. Whether the amino acid changes simply reflect the altered eating habits of obese individuals or whether the altered profile may play a role in appetite or energy regulation is not known.

Entities:  

Keywords:  amino acid; chromosome 15 deletion; exogenous obesity; hypopigmentation

Year:  1990        PMID: 25505361      PMCID: PMC4258711     

Source DB:  PubMed          Journal:  Dysmorphol Clin Genet        ISSN: 0893-6633


  7 in total

1.  Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome.

Authors:  M G Butler; F J Meaney; C G Palmer
Journal:  Am J Med Genet       Date:  1986-03

Review 2.  Chromosome 15 anomalies and the Prader-Willi syndrome: cytogenetic analysis.

Authors:  M G Mattei; N Souiah; J F Mattei
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  Oculocutaneous albinoidism as a manifestation of reduced neural crest derivatives in the Prader-Willi syndrome.

Authors:  H M Hittner; R A King; V M Riccardi; D H Ledbetter; R P Borda; R E Ferrell; F L Kretzer
Journal:  Am J Ophthalmol       Date:  1982-09       Impact factor: 5.258

4.  Chromosome 15 abnormalities and the Prader-Willi syndrome: a follow-up report of 40 cases.

Authors:  D H Ledbetter; J T Mascarello; V M Riccardi; V D Harper; S D Airhart; R J Strobel
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

5.  Prader-Willi syndrome: current understanding of cause and diagnosis.

Authors:  M G Butler
Journal:  Am J Med Genet       Date:  1990-03

6.  Hypopigmentation: a common feature of Prader-Labhart-Willi syndrome.

Authors:  M G Butler
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

7.  Hypopigmentation in the Prader-Willi syndrome.

Authors:  G L Wiesner; C M Bendel; D P Olds; J G White; D C Arthur; D W Ball; R A King
Journal:  Am J Hum Genet       Date:  1987-05       Impact factor: 11.025

  7 in total
  2 in total

1.  Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone.

Authors:  Krystal A Irizarry; James Bain; Merlin G Butler; Olga Ilkayeva; Michael Muehlbauer; Andrea M Haqq; Michael Freemark
Journal:  Clin Endocrinol (Oxf)       Date:  2015-04-01       Impact factor: 3.478

2.  Prader-Willi syndrome: current understanding of cause and diagnosis.

Authors:  M G Butler
Journal:  Am J Med Genet       Date:  1990-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.